C3.ai vs Egain
AI and EGAN side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AI and EGAN compare
C3.ai is the larger company, worth 12 times as much as Egain ($2.0B against $163M).
Egain grew revenue faster over the last twelve months (3.1% versus −37.5% for C3.ai).
Egain keeps more of each dollar of sales as profit, with a net margin of 9.7% compared with −192% at C3.ai.
Egain scores higher on the StockData Score (17 against 6 for C3.ai), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AI | EGAN |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $163M |
| Share price | $12.19 | $6.22 |
| Change, 1 year | −24.2% | −59.0% |
| Change, 5 years | −69.5% | −42.3% |
| Beta (5Y) | 2.36 | 0.75 |
| Employees | 764 | 422 |
| StockData Score | ||
| Total score | 6 | 17 (better) |
| Valuation score | 1 | 6 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 19.4× |
| P/S | 8.4× | 1.8× (better) |
| P/B | 2.8× | 1.9× (better) |
| EV/EBITDA | – | 11.2× |
| P/FCF | – | 7.9× |
| PEG | – | 0.26 |
| FCF yield | −7.9% | 12.6% (better) |
| Fair value | $10.55 | $8.85 |
| Margin of safety | −15.5% | 29.7% (better) |
| Growth | ||
| Revenue growth (TTM) | −37.5% | 3.1% (better) |
| Revenue growth, 5Y average | 6.4% (better) | 3.1% |
| Net income growth (TTM) | – | −72.5% |
| EPS growth (TTM) | – | −71.7% |
| EPS growth, 5Y average | – | 8.8% |
| Profitability | ||
| Gross margin | 29.1% | 73.4% (better) |
| Operating margin | −203% | 8.7% (better) |
| Net margin | −192% | 9.7% (better) |
| FCF margin | −67.0% | 22.5% (better) |
| Return on equity | −59.8% | 10.8% (better) |
| Return on invested capital | −570% | 45.6% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 6.16 (better) | 1.73 |
| Altman Z-score | 2.80 (better) | −0.00 |
| Piotroski F-score | 2 | 7 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 7.1% |
| Shareholder yield | 0.00% | 7.1% (better) |
| Ownership | ||
| Held by institutions | 60.4% | 55.4% |
| Held by insiders | 19.2% | 72.3% |
| Insider net buying, 12 months | −$67.0M | −$366K (better) |
| Short interest, % of float | 32.4% | 15.0% |
Go deeper
- AI stock overview
- AI income statement
- AI valuation and score
- EGAN stock overview
- EGAN income statement
- EGAN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.